Hey guys,
I am totally new to valuation of pharma companies and have to do it for the university. Do you have a idea, why companies have R&D expenses on the income statement and does not involve them on the free cash flow statement as capex for example? Our team has no clue and we searched for it for quite a bit now..
Thank you!
| +262 | Why UBS Is the Worst Place to Start Your IB Career | 40 | 1d |
| +219 | UBS 2nd Year Analyst Q&A (2026) | 41 | 12h |
| +98 | What's your craziest "hardo" story? | 16 | 21h |
| +52 | Rogo AI | 22 | 15h |
| +52 | Wolf of Wall Street vs. Reality: Anyone else feel scammed by the movies? | 19 | 2h |
| +49 | Suspended for a Year | 21 | 7h |
| +49 | Elite Boutique interview questions | 17 | 1d |
| +33 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 7 | 1h |
| +30 | Rate my non-target resume | 15 | 16h |
| +25 | so confused about 28 SA timeline | 27 | 5m |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
I had to deal with this during my summer internship and what I understood was that they liked to call it an expense in the same manner as SG&A or whatever and not as capex because , while capex ties in to certain types of investments, they are not treating drug development as an investment but rather as some form of business expense. If they were to invest in, say real estate, it would be treated as an actual investment. R&D has no guarantee of any return and a pharma or biotech cant really survive without it, so they treat it as a business expense. but sometimes they dont lol I saw them do both. what company(s) are you looking at
Thank you very much for your answer. I think i got the problem here, but not 100% for sure.
I think US Gaap has R&D as expense. Hower, IFRS has R as expense but capitalizes D under some circumstances (as intangible asset) and is amortising it over a period.
I hope i am right, pretty tricky :D
you might be right - i didnt do much regarding ifrs. is the line item giving you any issues in valuation/modeling/whatever youre doing for this project?
Itaque non qui quo incidunt. Rerum tempora voluptas et mollitia et aut doloribus. Temporibus cupiditate est odit. Enim commodi accusamus ut magni. Molestiae eligendi dolorem autem repellendus voluptas nisi molestiae.
Harum similique aut ducimus culpa ut et. Est minima ipsam qui aspernatur. Pariatur sed at est sed.
Aperiam illo et molestiae voluptas omnis id. Quod quis culpa dolor. Magni neque tempora atque impedit. Officia officiis deleniti vel in ipsa ut.
Dolorum voluptatem sint quas eius aut. Facilis ut cum odio impedit nulla. Fugit blanditiis perspiciatis pariatur veritatis sint sequi. Consequatur temporibus rem quaerat facere inventore laborum explicabo. Tempore maiores mollitia ducimus sapiente.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...